Efficacy of Low‐ and High‐Dose Trilostane Treatment in Dogs (< 5 kg) with Pituitary‐Dependent Hyperadrenocorticism

Journal of Veterinary Internal Medicine

K.-D. Cho²  J.-H. Kang²  D. Chang¹  K.-J. Na³ 

[1] Laboratory of Veterinary Diagnostic Imaging, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea;Laboratory of Veterinary Internal Medicine, Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea;Laboratory of Veterinary Laboratory Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea

关键词: Adrenocorticotropic hormone;    Cortisol;    Cushing's disease;    Dogs;   

DOI  :  10.1111/jvim.12007

来源: Wiley

【 摘 要 】

Abstract

Background

Trilostane is commonly used to treat pituitary-dependent hyperadrenocorticism (PDH) in dogs. There are differing opinions regarding the dose and frequency of trilostane administration in dogs with PDH.

Objectives

To compare the efficacy of 2 trilostane protocols in the treatment of dogs with PDH.

Animals

Sixteen client-owned dogs with PDH and a body weight <5 kg.

Methods

Prospective observational study. Group A (n=9; low-dose treatment group) received 0.78 ± 0.26 mg of trilostane/kg PO every 12 h and group B (n = 7; high-dose treatment group) 30 mg of trilostane/dog PO every 24 h. All of the dogs were reassessed at 2, 4, 8, 12, 16, and 24 weeks after the initiation of treatment.

Results

An improvement in both ACTH-stimulated serum cortisol concentrations and clinical signs occurred more slowly in group A than in group B; however, after 20 weeks of treatment, 2/7 dog in group B had clinical signs and abnormal laboratory findings consistent with hypoadrenocorticism. At 24 weeks, an improvement in the clinical findings of all of the dogs in both groups was detected.

Conclusions and clinical importance

In dogs with PDH, twice-daily administration of low-dose trilostane is an effective approach to the management of PDH. In addition, our results suggest fewer potential adverse effects if trilostane is administered twice daily in the lower dose.

【 授权许可】

Unknown   
Copyright © 2012 by the American College of Veterinary Internal Medicine